Funder: [National Institutes of Health - https://www.nih.gov]
Due Dates: January 5, 2027 (Next due date) | Standard SBIR/STTR due dates apply
Funding Amounts: Typical SBIR/STTR Phase I awards: up to $256,000 for 6-12 months; Phase II awards: up to $1.7 million for 2 years; Commercialization Readiness Pilot (CRP) and Phase IIB also available.
Summary: Supports small businesses in developing improved or alternative clinical diagnostics that address health inequities caused by current assays or point-of-care devices lacking diverse patient representation.
Key Information: Clinical trials are NOT allowed under this R41/R42 funding opportunity. Applicants must identify and address specific health disparities perpetuated by existing diagnostics.